[A comparison of the in vitro susceptibility of three bacteria to beta-lactamase inhibitors and to ampicillin and cefazolin].
In this study in vitro susceptibility of three different bacteria, which are able to release various Beta-lactamases, against combinations of clavulanic acid + amoxicillin and sulbactam + ampicillin were compared with susceptibility to ampicillin alone and cefazolin of same strains.
Acar
N
N
Ankara Hastanesi Enfeksiyon Hastaliklari Kliniği Asistani.
Diri
M C
MC
Türkyilmaz
F R
FR
D000658:Amoxicillin / Q000494:pharmacology; D019980:Amoxicillin-Potassium Clavulanate Combination; D000667:Ampicillin / Q000494:pharmacology*; D002437:Cefazolin / Q000494:pharmacology*; D002969:Clavulanic Acids / Q000494:pharmacology; D004338:Drug Combinations; D004359:Drug Therapy, Combination / Q000494:pharmacology; D004926:Escherichia coli / Q000187:drug effects* / Q000201:enzymology; D007709:Klebsiella / Q000187:drug effects* / Q000201:enzymology; D013211:Staphylococcus aureus / Q000187:drug effects* / Q000201:enzymology; D013407:Sulbactam / Q000494:pharmacology; D065093:beta-Lactamase Inhibitors; D001618:beta-Lactamases / Q000096:biosynthesis
D002969:Clavulanic Acids; D004338:Drug Combinations; D065093:beta-Lactamase Inhibitors; D019980:Amoxicillin-Potassium Clavulanate Combination; D000667:Ampicillin; D000658:Amoxicillin; D001618:beta-Lactamases; D002437:Cefazolin; D013407:Sulbactam
Uç ayri bakteri türünün beta-laktam inhibitörlü bileşiklere invitro duyarliliklarinin ampisilin ve sefazolin'e duyarliliklariyla karşilaştirilmasi.